About [(3S,10R,13S)-1,1,2,2,4,4,6,11,11,12,12,16-dodecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-3,7,8,9,14,15-hexahydrocyclopenta[a]phenanthren-3-yl] acetate;[(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-10,13-bis(trideuteriomethyl)-17-(4,5,6-trideuterio-2-methyl-3-pyridinyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-yl] acetate;(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-ol;(10R,13S)-1,1,2,2,4,6,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydrocyclopenta[a]phenanthren-3-one
[(3S,10R,13S)-1,1,2,2,4,4,6,11,11,12,12,16-dodecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-3,7,8,9,14,15-hexahydrocyclopenta[a]phenanthren-3-yl] acetate;[(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-10,13-bis(trideuteriomethyl)-17-(4,5,6-trideuterio-2-methyl-3-pyridinyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-yl] acetate;(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-ol;(10R,13S)-1,1,2,2,4,6,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydrocyclopenta[a]phenanthren-3-one (PubChem CID 157420330) has the molecular formula C101H128N4O6
and a molecular weight of 1587.72 g/mol. Its IUPAC name is [(3S,10R,13S)-1,1,2,2,4,4,6,11,11,12,12,16-dodecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-3,7,8,9,14,15-hexahydrocyclopenta[a]phenanthren-3-yl] acetate;[(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-10,13-bis(trideuteriomethyl)-17-(4,5,6-trideuterio-2-methyl-3-pyridinyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-yl] acetate;(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-ol;(10R,13S)-1,1,2,2,4,6,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydrocyclopenta[a]phenanthren-3-one.
Frequently Asked Questions
What is the IUPAC name of [(3S,10R,13S)-1,1,2,2,4,4,6,11,11,12,12,16-dodecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-3,7,8,9,14,15-hexahydrocyclopenta[a]phenanthren-3-yl] acetate;[(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-10,13-bis(trideuteriomethyl)-17-(4,5,6-trideuterio-2-methyl-3-pyridinyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-yl] acetate;(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-ol;(10R,13S)-1,1,2,2,4,6,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydrocyclopenta[a]phenanthren-3-one?
The IUPAC name of [(3S,10R,13S)-1,1,2,2,4,4,6,11,11,12,12,16-dodecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-3,7,8,9,14,15-hexahydrocyclopenta[a]phenanthren-3-yl] acetate;[(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-10,13-bis(trideuteriomethyl)-17-(4,5,6-trideuterio-2-methyl-3-pyridinyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-yl] acetate;(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-ol;(10R,13S)-1,1,2,2,4,6,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydrocyclopenta[a]phenanthren-3-one (CID 157420330) is [(3S,10R,13S)-1,1,2,2,4,4,6,11,11,12,12,16-dodecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-3,7,8,9,14,15-hexahydrocyclopenta[a]phenanthren-3-yl] acetate;[(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-10,13-bis(trideuteriomethyl)-17-(4,5,6-trideuterio-2-methyl-3-pyridinyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-yl] acetate;(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-ol;(10R,13S)-1,1,2,2,4,6,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydrocyclopenta[a]phenanthren-3-one.
What is the SMILES notation for [(3S,10R,13S)-1,1,2,2,4,4,6,11,11,12,12,16-dodecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-3,7,8,9,14,15-hexahydrocyclopenta[a]phenanthren-3-yl] acetate;[(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-10,13-bis(trideuteriomethyl)-17-(4,5,6-trideuterio-2-methyl-3-pyridinyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-yl] acetate;(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-ol;(10R,13S)-1,1,2,2,4,6,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydrocyclopenta[a]phenanthren-3-one?
The canonical SMILES for [(3S,10R,13S)-1,1,2,2,4,4,6,11,11,12,12,16-dodecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-3,7,8,9,14,15-hexahydrocyclopenta[a]phenanthren-3-yl] acetate;[(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-10,13-bis(trideuteriomethyl)-17-(4,5,6-trideuterio-2-methyl-3-pyridinyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-yl] acetate;(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-ol;(10R,13S)-1,1,2,2,4,6,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydrocyclopenta[a]phenanthren-3-one is [2H]C1=C2C([2H])([2H])C([2H])([2H])C3C(CC([2H])([2H])[C@]4(C([2H])([2H])[2H])C(c5c([2H])nc([2H])c([2H])c5[2H])=C([2H])C([2H])([2H])C34)[C@@]2(C([2H])([2H])[2H])C([2H])([2H])C([2H])([2H])C1=O.[2H]C1=C2C([2H])([2H])[C@@H](O)C([2H])([2H])C([2H])([2H])[C@]2(C([2H])([2H])[2H])C2CC([2H])([2H])[C@]3(C([2H])([2H])[2H])C(c4c([2H])nc([2H])c([2H])c4[2H])=C([2H])C([2H])([2H])C3C2C1([2H])[2H].[2H]C1=C2C([2H])([2H])[C@@H](OC(C)=O)C([2H])([2H])C([2H])([2H])[C@]2(C([2H])([2H])[2H])C2C(C1)C1CC([2H])=C(c3c([2H])nc([2H])c([2H])c3[2H])[C@@]1(C([2H])([2H])[2H])C([2H])([2H])C2([2H])[2H].[2H]C1=C2C([2H])([2H])[C@@H](OC(C)=O)C([2H])([2H])C([2H])([2H])[C@]2(C([2H])([2H])[2H])C2CC([2H])([2H])[C@]3(C([2H])([2H])[2H])C(c4c(C)nc([2H])c([2H])c4[2H])=C([2H])C([2H])([2H])C3C2C1([2H])[2H].
What is the InChIKey of [(3S,10R,13S)-1,1,2,2,4,4,6,11,11,12,12,16-dodecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-3,7,8,9,14,15-hexahydrocyclopenta[a]phenanthren-3-yl] acetate;[(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-10,13-bis(trideuteriomethyl)-17-(4,5,6-trideuterio-2-methyl-3-pyridinyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-yl] acetate;(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-ol;(10R,13S)-1,1,2,2,4,6,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydrocyclopenta[a]phenanthren-3-one?
The InChIKey is BPIFVUAIAQIXKJ-RTAVTFOASA-N. The full InChI is InChI=1S/C27H35NO2.C26H33NO2.C24H31NO.C24H29NO/c1-17-21(6-5-15-28-17)23-9-10-24-22-8-7-19-16-20(30-18(2)29)11-13-26(19,3)25(22)12-14-27(23,24)4;1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25;2*1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h5-7,9,15,20,22,24-25H,8,10-14,16H2,1-4H3;4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3;3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3;3-4,7,13-15,19,21-22H,5-6,8-12H2,1-2H3/t20-,22?,24?,25?,26-,27+;20-,21?,23?,24?,25-,26+;18-,19?,21?,22?,23-,24+;19?,21?,22?,23-,24+/m0000/s1/i3D3,4D3,5D,6D,7D,8D2,9D,10D2,11D2,13D2,14D2,15D,16D2;2D3,3D3,4D,5D,6D,8D,10D2,11D2,12D2,13D2,14D,15D2,16D;1D3,2D3,3D,4D,5D,6D2,7D,8D2,9D2,11D2,12D2,13D,14D2,15D;1D3,2D3,3D,4D,5D2,6D2,7D,8D2,9D2,11D2,12D2,13D,14D,15D.
What are the key properties of [(3S,10R,13S)-1,1,2,2,4,4,6,11,11,12,12,16-dodecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-3,7,8,9,14,15-hexahydrocyclopenta[a]phenanthren-3-yl] acetate;[(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-10,13-bis(trideuteriomethyl)-17-(4,5,6-trideuterio-2-methyl-3-pyridinyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-yl] acetate;(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-ol;(10R,13S)-1,1,2,2,4,6,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydrocyclopenta[a]phenanthren-3-one?
[(3S,10R,13S)-1,1,2,2,4,4,6,11,11,12,12,16-dodecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-3,7,8,9,14,15-hexahydrocyclopenta[a]phenanthren-3-yl] acetate;[(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-10,13-bis(trideuteriomethyl)-17-(4,5,6-trideuterio-2-methyl-3-pyridinyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-yl] acetate;(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-ol;(10R,13S)-1,1,2,2,4,6,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydrocyclopenta[a]phenanthren-3-one has a molecular weight of 1587.72 g/mol, XLogP of 23.25, 14 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [(3S,10R,13S)-1,1,2,2,4,4,6,11,11,12,12,16-dodecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-3,7,8,9,14,15-hexahydrocyclopenta[a]phenanthren-3-yl] acetate;[(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-10,13-bis(trideuteriomethyl)-17-(4,5,6-trideuterio-2-methyl-3-pyridinyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-yl] acetate;(3S,10R,13S)-1,1,2,2,4,4,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydro-3H-cyclopenta[a]phenanthren-3-ol;(10R,13S)-1,1,2,2,4,6,6,7,7,12,12,15,15,16-tetradecadeuterio-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-10,13-bis(trideuteriomethyl)-8,9,11,14-tetrahydrocyclopenta[a]phenanthren-3-one is sourced from PubChem (CID 157420330), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).